Last updated: April 25, 2026
Who Supplies Loperamide Hydrochloride to the Pharmaceutical Market?
Which suppliers produce loperamide hydrochloride (API) ?
Loperamide hydrochloride is sourced globally from multiple API manufacturers across regulatory-grade and generic supply channels. The supplier set typically includes:
- Large-scale small-molecule API manufacturers that supply DMFs and commercial API for generics and branded products.
- Specialty chemical manufacturers that supply loperamide HCl for downstream formulation and packaging.
Patent-grade and regulatory filings (DMF/ASMF-linked supply) normally determine eligibility for inclusion in branded-generic qualification. In practice, sourcing is handled through approved distributor networks and raw material qualification processes tied to quality systems and regulatory status.
Who are the established commercial API suppliers for loperamide hydrochloride?
The market commonly lists loperamide hydrochloride API from the following categories of suppliers:
- Teva / Sandoz / generic API supply partners (often via contract manufacturing and approved API sources)
- Indian and Chinese API producers that regularly appear in global generic supply chains
- European specialty chemical firms that supply APIs or intermediates used to manufacture loperamide HCl
Which distributors and wholesalers commonly carry loperamide hydrochloride API?
Downstream buyers often obtain API through:
- Global chemical distributors that maintain catalogs of pharmaceutical-grade APIs
- Regional pharma wholesalers that supply qualified generic manufacturing sites
- CMO-linked sourcing where formulation partners control API procurement under quality agreements
Because loperamide is a widely manufactured small-molecule, distributor availability is high, but regulatory acceptability depends on DMF/ASMF status, CoA/CoC, and impurity profile compliance.
What matters for supplier qualification in loperamide hydrochloride sourcing?
What quality and documentation do pharma buyers require?
Supplier qualification for loperamide hydrochloride generally hinges on:
- Regulatory dossier status (DMF/ASMF where applicable)
- Current Good Manufacturing Practice (cGMP) compliance and audit results
- Impurity profile control (residuals and process-related impurities within established limits)
- Particle size and solid-state attributes if the API grade is intended for specific formulation tech
- Traceability and change control (batch genealogy, raw material sourcing, validated cleaning)
Which endpoints determine whether an API is accepted?
- Identity (HPLC/UV and/or IR corroboration)
- Assay and potency (HPLC)
- Related substances (HPLC impurity panel)
- Residual solvents (GC where applicable)
- Water content (Karl Fischer if relevant)
- Sulfated ash/other pharmacopeial tests depending on pharmacopeia used
Supplier landscape by sourcing route
Do buyers typically use direct API manufacturers or intermediated supply?
Most commercial procurement uses a mix:
- Direct manufacturer supply for large-volume, long-term supply agreements tied to validated processes
- Distributor or CMO-sourced supply when volume is moderate, timelines are tight, or specific regulatory documentation is already held by the downstream integrator
Key market reality: loperamide hydrochloride is widely generic
Loperamide hydrochloride is an off-patent, widely manufactured antidiarrheal active with broad API supply coverage across Asia, Europe, and North America. This drives:
- High sourcing redundancy
- Competition on cost and documentation turn-around
- Qualification driven by dossier acceptance and batch-to-batch impurity consistency rather than scarce supply
Key Takeaways
- Loperamide hydrochloride API is supplied by multiple global manufacturers and distributed through qualified pharma supply channels.
- Supplier selection is governed by DMF/ASMF and cGMP documentation, plus impurity profile control and change-control discipline.
- For qualification, buyers rely on batch-level CoA/CoC, pharmacopeial testing, and dossier alignment, not catalog availability alone.
FAQs
1) Are there many suppliers for loperamide hydrochloride API?
Yes. It is a widely manufactured small-molecule API with broad global supply coverage.
2) What documentation usually decides supplier approval?
DMF/ASMF alignment, cGMP status, audit outcomes, and the supplier’s ability to consistently meet impurity and testing specifications.
3) Is distributor supply acceptable for pharma manufacturing?
Often yes, if the distributor supplies API that matches the buyer’s regulatory documentation and provides full batch traceability and CoA/CoC.
4) What quality tests matter most for loperamide HCl?
Identity, assay, related substances, residual solvents (when applicable), and additional pharmacopeial checks per the agreed specification.
5) Can supplier changes affect product quality?
Yes, because impurity profiles and solid-state/formulation-relevant properties can vary across manufacturers and processes, making change control and bridging critical.
References (APA)
[1] U.S. Food and Drug Administration. (n.d.). Drug Master Files (DMF). https://www.accessdata.fda.gov/scripts/cder/dmf/
[2] U.S. Food and Drug Administration. (n.d.). Current Good Manufacturing Practice (CGMP). https://www.fda.gov/drugs/current-good-manufacturing-practices-cgmp-drugs
